Training activity information
Details
Analyse and interpret the results of lymphoid clonality assessment (Ig and TR gene rearrangements) to aid the diagnosis of suspected mature lymphoid malignancies
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
Considerations are suggestions about what may be useful for the trainee to think about while undertaking a training activity. They should not be considered as a mandatory checklist. Trainees should not be expected to demonstrate or provide evidence for each of the considerations listed.
- Principles of the molecular testing strategy
- Importance of IQC and EQA
- Best practice guidelines for reporting, including recommendations for patient treatment and management, follow up, further testing or clinical trials if relevant
- Correct scientific and clinical terminology, including HGVS nomenclature
- Communication of complex scientific information to the multidisciplinary team
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 4 |
Outcome
Analyse, interpret and prepare interpretive reports for common haematological malignancies, including results for somatic variants, clonality, and somatic hypermutation. |
| # 5 |
Outcome
Interpret the associated IQC and EQA of the laboratory tests for investigation of haematological malignancies. |
| # 6 |
Outcome
Practice with the relevant specialties for the diagnosis, monitoring and management of haematological malignancies. |